Further Reading


  1. Baldisseri M. Impaired healthcare professional. Critical Care Medicine 2007; 35 (Suppl 2): S106-16.

  2. Berge K, Seppala MD, Schipper AM. Chemical Dependency and the Physician. Mayo Clinic Proceedings 2009; 84: 625-31.

  3. Domino KB et al. Risk Factors for Relapse in Health Care Professionals with Substance Use Disorders. JAMA 2005; 293:1453-60.

  4. Working group on the misuse of alcohol and drugs by doctors. London: British Medical Association, 1998.

  5. Skipper GE, Campbell MD, DuPont RL. Anesthesiologists with Substance Use Disorders; A 5-Yea Outcome Study from 16 State Physician Health Programs. Anesthesia & Analgesia 2009; 109: 891- 96.

  6. Hughes PH, Storr CL.et al. Physician substance use by medical specialty. J Addict Dis 1999; 18(2): 23–37.

  7. Gallegos KV, Browne CH, Veit FW, Talbott GD. Addiction in anesthesiologists: drug access and patterns of substance abuse. QRB Qual Rev Bull. 1988 Apr;14(4):116-22

  8. Dobson B. Head of Case Review GMC 2010; (personal communication).

  9. Talbott GD, Gallegos KV, Wilson PO, Porter TL. The Medical Association of Georgia's Impaired Physicians Program Review of the First 1000 Physicians: Analysis of Specialty. Journal of the American Medical Association 1987; 257: 2927-30.

  10. Gallegos KV, Lubin BH, Bowers C, Blevins JW, Talbott GD, Wilson PO. Relapse and recovery: Five to ten year follow-up study of chemically dependent physicians – the Georgia experience. Maryland Medical Journal 1992; 41: 315-9.

  11. Lutsky I,Hopwood M, Abram SE, Cerletty JM, Hoffman RG, Kampine JP. Use of psychoactive substances in three medical specialties:anaesthesia, medicine and surgery CanadianJournalofAnaesthesia 1994; 41:561-7

  12. Silverstein JH, Silva DA, Iberti TJ. Opioid addiction in Anesthesiology. Anesthesiology 1993; 79: 354-75.

  13. Brewster JM, Kaufmann M. Characteristics and outcomes of doctors in a substance abuse monitoring programme in Canada: prospective descriptive study. British Medical Journal 2008; 337:a2098 (accessed 15.10.2009).

  14. Foll BLe, Gallo A, Strat YLe, Lu L, Gorwood P. Genetics of dopamine receptors and drug addiction: a comprehensive review. Behavioural Pharmacology 2009; 20: 1-17.

  15. Drgon T, D'Addario C, Uhl GR. Linkage disequilibrium, haplotype and association studies of a chromosome 4 GABA receptor gene cluster: Candidate gene variants for addictions. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2006; 141B: 854 – 860.

  16. The Health and Social Care Information Centre. NHS Information Centre Statistics on Alcohol England 2009; 13-14.

  17. The Health and Social Care Information Centre. NHS Information Centre: Statistics on Drug Misuse England 2007.

  18. Mayall RM. The way I see it... Helping addicted doctors. BMJ September 30th 2006 http://careers.bmj.com/careers/advice/view-article.html?id=1939

  19. Early P, Finver T. Addiction to Propofol: A Study of 22 Treatment Cases. J Addict Med 2013;00: 1–8.  journals.lww.com/journaladdictionmedicine/Documents/ADM200274.pdf